| 1 |
27873490 | EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells. | 2017 Jan |
1 |
| 2 |
26715573 | Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers. | 2016 Apr |
2 |
| 3 |
21404105 | A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer. | 2012 Jun |
2 |
| 4 |
19002384 | Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer. | 2009 Jun |
1 |
| 5 |
15367698 | ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. | 2004 Sep |
1 |